EDN1 and prostate carcinoma: However, these associations should be interpreted with caution as we are not able to completely isolate the effects of BMI from those of low testosterone in the current cohort; future studies among lean men with low testosterone or models of testosterone suppression (e.g., androgen deprivation therapy for prostate cancer) should further investigate how ET-1 is regulated by testosterone.